| Oh, what a tangled web |
| SM Grunberg |
|
JCO Jun 1 1989: 691–693.
[PDF]
|
 |
| Should single agents be standard therapy for urothelial tract tumors? |
| HI Scher |
|
JCO Jun 1 1989: 694–697.
[PDF]
|
|
| Can oncologists add? |
| ME Lippman |
|
JCO Jun 1 1989: 698–699.
[PDF]
|
|
|
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis |
| |
PJ Hesketh, WK Murphy, EP Lester, DR Gandara, A Khojasteh, E Tapazoglou, GP Sartiano, DR White, K Werner, and JM Chubb |
| |
JCO Jun 1 1989: 700–705.
[Abstract]
[PDF]
|
|
|
A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract |
| |
BL Hillcoat, D Raghavan, J Matthews, R Kefford, K Yuen, R Woods, I Olver, J Bishop, B Pearson, and G Coorey |
| |
JCO Jun 1 1989: 706–709.
[Abstract]
[PDF]
|
|
|
Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens |
| |
CK Osborne, L Kitten, and CL Arteaga |
| |
JCO Jun 1 1989: 710–717.
[Abstract]
[PDF]
|
|
|
Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease |
| |
TJ Kinsella, G Trivette, J Rowland, R Sorace, R Miller, B Fraass, SM Steinberg, E Glatstein, and RJ Sherins |
| |
JCO Jun 1 1989: 718–724.
[Abstract]
[PDF]
|
|
|
Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately? |
| |
AL Cheng, YC Chen, CH Wang, IJ Su, HC Hsieh, JY Chang, WS Hwang, WC Su, TW Liu, and HF Tien |
| |
JCO Jun 1 1989: 725–731.
[Abstract]
[PDF]
|
|
|
MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease |
| |
G Cimino, GP Biti, AP Anselmo, R Maurizi Enrici, GP Bellesi, A Bosi, L Cionini, V Mungai, G Papa, and P Ponticelli |
| |
JCO Jun 1 1989: 732–737.
[Abstract]
[PDF]
|
|
|
Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties |
| |
A Delmer, JP Marie, D Thevenin, M Cadiou, F Viguie, and R Zittoun |
| |
JCO Jun 1 1989: 738–746.
[Abstract]
[PDF]
|
|
|
Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse |
| |
P Bordigoni, JP Vernant, G Souillet, E Gluckman, D Marininchi, N Milpied, A Fischer, E Benz Lemoine, JP Jouet, and J Reiffers |
| |
JCO Jun 1 1989: 747–753.
[Abstract]
[PDF]
|
|
|
Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation |
| |
MJ Schell, VA McHaney, AA Green, LE Kun, FA Hayes, M Horowitz, and WH Meyer |
| |
JCO Jun 1 1989: 754–760.
[Abstract]
[PDF]
|
|
|
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor- prognosis head and neck cancer: a phase I-II study |
| |
EE Vokes, WR Panje, RL Schilsky, R Mick, AM Awan, WJ Moran, MD Goldman, AG Tybor, and RR Weichselbaum |
| |
JCO Jun 1 1989: 761–768.
[Abstract]
[PDF]
|
|
|
Predictability of the survival of patients with advanced ovarian cancer |
| |
JC van Houwelingen, WW ten Bokkel Huinink, ME van der Burg, AT van Oosterom, and JP Neijt |
| |
JCO Jun 1 1989: 769–773.
[Abstract]
[PDF]
|
|
|
Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma |
| |
A Chachoua, R Krigel, F Lafleur, R Ostreicher, M Speer, L Laubenstein, J Wernz, P Rubenstein, E Zang, and A Friedman-Kien |
| |
JCO Jun 1 1989: 774–780.
[Abstract]
[PDF]
|
|
|
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry |
| |
JB Lesesne, N Rothschild, B Erickson, S Korec, R Sisk, J Keller, M Arbus, PV Woolley, L Chiazze, and PS Schein |
| |
JCO Jun 1 1989: 781–789.
[Abstract]
[PDF]
|
|
|
A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone |
| |
J Greidanus, EG de Vries, NH Mulder, DT Sleijfer, DR Uges, B Oosterhuis, and PH Willemse |
| |
JCO Jun 1 1989: 790–797.
[Abstract]
[PDF]
|
|
|
The safety of dental extractions in patients with hematologic malignancies |
| |
SK Williford, PL Salisbury, 3d, JE Peacock, Jr, JM Cruz, BL Powell, ES Lyerly, and RL Capizzi |
| |
JCO Jun 1 1989: 798–802.
[Abstract]
[PDF]
|
|
|
Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects |
| |
RR Love |
| |
JCO Jun 1 1989: 803–815.
[Abstract]
[PDF]
|
|
| Applications of LhRh agonists against a wide range of gynecologic cancers |
| HW Bruckner and BT Motwani |
|
JCO Jun 1 1989: 816–817.
[PDF]
|
|
| Mesna: continuous or bolus infusion? |
| PH Willemse and EG de Vries |
|
JCO Jun 1 1989: 817–819.
[PDF]
|
|
